![Key Questions for Legislators on the Institute for Clinical and Economic Review (ICER) | Health Care Latest News Key Questions for Legislators on the Institute for Clinical and Economic Review (ICER) | Health Care Latest News](https://pioneerinstitute.org/wp-content/uploads/27854267179_5d8dc9c17f_o-1.jpg)
Key Questions for Legislators on the Institute for Clinical and Economic Review (ICER) | Health Care Latest News
![The Institute for Clinical and Economic Review (ICER) Will Now Leverage Data and Insights From IPD Analytics The Institute for Clinical and Economic Review (ICER) Will Now Leverage Data and Insights From IPD Analytics](https://mma.prnewswire.com/media/884883/Institute_for_Clinical_and_Economic_Review_Logo.jpg?p=facebook)
The Institute for Clinical and Economic Review (ICER) Will Now Leverage Data and Insights From IPD Analytics
![Digital Health Outcomes launched interactive health economic modeling platform together with the Institute for Clinical and Economic review (ICER). | Digital Health Outcomes Digital Health Outcomes launched interactive health economic modeling platform together with the Institute for Clinical and Economic review (ICER). | Digital Health Outcomes](https://digitalho.com/wp-content/uploads/2021/02/screenshot-2021-02-03-at-15.02.15.png)
Digital Health Outcomes launched interactive health economic modeling platform together with the Institute for Clinical and Economic review (ICER). | Digital Health Outcomes
![Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates](https://www.ohe.org/sites/default/files/styles/publication-full/public/publication-covers/Value%2C%20Access%2C%20and%20Incentives%20for%20Innovation%20-%20Policy%20Perspectives%20on%20Alternative%20Models%20for%20Pharmaceutical%20Rebates.jpg?itok=fgez1O_A)
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
![ICER's Final Report on Peanut Allergy Treatments: Clinical Evidence Does Not Yet Demonstrate That Long-Term Benefits of Desensitization Outweigh Short-Term Risks | SnackSafely.com ICER's Final Report on Peanut Allergy Treatments: Clinical Evidence Does Not Yet Demonstrate That Long-Term Benefits of Desensitization Outweigh Short-Term Risks | SnackSafely.com](https://media.snacksafely.com/wp-content/uploads/2019/07/ICER-Final-Report.jpg)
ICER's Final Report on Peanut Allergy Treatments: Clinical Evidence Does Not Yet Demonstrate That Long-Term Benefits of Desensitization Outweigh Short-Term Risks | SnackSafely.com
![White Paper: The Growing Influence of the Institute of Clinical and Economic Review on Payer Decisions in the US - Evidera White Paper: The Growing Influence of the Institute of Clinical and Economic Review on Payer Decisions in the US - Evidera](https://www.evidera.com/wp-content/uploads/2019/10/shutterstock-1023953008-paper-1600x600-1.jpg)
White Paper: The Growing Influence of the Institute of Clinical and Economic Review on Payer Decisions in the US - Evidera
![Institute for Clinical and Economic Review (ICER) - News, Articles, Whitepapers - Drug Target Review Institute for Clinical and Economic Review (ICER) - News, Articles, Whitepapers - Drug Target Review](https://www.drugtargetreview.com/wp-content/uploads/Cancer-cells-5.jpg)
Institute for Clinical and Economic Review (ICER) - News, Articles, Whitepapers - Drug Target Review
![Milliman Study on the Utility of ICER Reports for Private Payer Drug Coverage Decision-Making | PhRMA Milliman Study on the Utility of ICER Reports for Private Payer Drug Coverage Decision-Making | PhRMA](https://phrma.org/-/media/Project/PhRMA/PhRMA-Org/PhRMA-Org/Teaser-Image/Advocacy/md_1000x635_ICER-new2.jpg)
Milliman Study on the Utility of ICER Reports for Private Payer Drug Coverage Decision-Making | PhRMA
![Steven Pearson, Founder and President of the Institute for Clinical and Economic Review (ICER), poses for a portrait for Reuters at ICER's offices in Boston, Massachusetts, U.S., January 2, 2020. Picture taken Steven Pearson, Founder and President of the Institute for Clinical and Economic Review (ICER), poses for a portrait for Reuters at ICER's offices in Boston, Massachusetts, U.S., January 2, 2020. Picture taken](https://l450v.alamy.com/450v/2cggaft/steven-pearson-founder-and-president-of-the-institute-for-clinical-and-economic-review-icer-poses-for-a-portrait-for-reuters-at-icers-offices-in-boston-massachusetts-us-january-2-2020-picture-taken-january-2-2020-reutersbrian-snyder-to-match-special-report-usa-drugpricinglobbying-2cggaft.jpg)